Scott Schliebner-A Growth Mindset, Commitment to Patients and Rare Disease

Scott Schliebner is an industry executive with deep knowledge of clinical research coupled with a commitment to patients and a growth mindset. He is a true industry disruptor, not afraid to step out of his comfort zone. Scott has a passion for building teams and nurturing others towards their goals. In this episode we discuss adopting a patient focused approach throughout drug development. We talk about the implications when we as an industry fail to take into account what patients really want. Scott shares about differences in the Rare Disease community and how to address some of the challenges and then apply those learnings to other areas. Scott shares tips for empowering patients and how to assess patient burden and ensure ROI. Enjoy this episode! Scott Schlieber takes people, teams, and organizations further than they would otherwise go. A strategic, innovative, and commercially-oriented clinical drug development executive with 30 years experience across the biopharma, CRO, and non-profit sectors. Scott creates, builds, transforms, and accelerates growth for clinical research organizations. He drives commercial success through relationship-building, strategic partnerships, creativity, transparency, and integrity. Scott is passionate about patient-centric research and developing innovative approaches to accelerate clinical drug development.